Otros idiomas BeiGene, Ltd. Deutsche Boerse AG

Acciones

49B

KYG1146Y1017

Mercado cerrado - Deutsche Boerse AG Otros sitios de cotización 12:53:38 31/05/2024			Varia. Cinco días.	Varia. 1 de enero.
10,8 ^EUR	+2,86 %		+0,93 %	-12,90 %

28/05	BriaCell anuncia un acuerdo de suministro clínico con BeiGene para el primer estudio en humanos de Bria-OTS	MT
28/05	BriaCell Therapeutics y BeiGene se asocian para probar la combinación de tratamientos contra el cáncer de ambas empresas	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS First in Human Study	28/05
BriaCell Therapeutics, BeiGene Partner to Test Combination of Companies' Cancer Treatments	28/05
BriaCell Therapeutics Corp. Announces Clinical Supply Agreement with BeiGene, Ltd. for Bria-OTS First in Human Study	28/05
BeiGene, Ltd. Announces New Analyses for BRUKINSA® (zanubrutinib) At ASCO Underscore Differentiated Clinical Profile for Treatment of CLL and SLL	24/05
Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India	21/05
Glenmark Specialty S.A. Announces an Exclusive Marketing and Distribution Agreement with BeiGene	21/05
BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024	14/05
Beigene Q1 Loss Shrinks as Revenue Grows; Company's Shares Nearly 7% Up	09/05
BeiGene presenta los resultados financieros del primer trimestre de 2024 y actualiza sus actividades	09/05
Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday	08/05
BeiGene's Q1 Loss Narrows as Revenue Rises	08/05
BeiGene, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
BeiGene, Ltd. Anticipates Opening of Biologics Manufacturing Facility and Clinical R&D Center at the Princeton West Innovation Campus in Hopewell, New Jersey, in July 2024	08/05
Sector Update: Health Care Stocks Rise in Afternoon Trading	23/04
BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise	23/04
Technology Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading	23/04
BeiGene, Ltd. Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer	23/04
Western Drugmakers Seeking Alternative Suppliers as US Looks to Restrict Chinese Biotech	11/04
Western Drugmakers Seeking Alternative Suppliers as US Looks to Restrict Chinese Biotech	11/04
BeiGene Opens New Factory in Guangzhou for Antibody-Drug Conjugates	10/04

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas BeiGene, Ltd. Deutsche Boerse AG

Acciones

49B

KYG1146Y1017

Otros idiomas

Filtros